400
Participants
Start Date
December 10, 2007
Primary Completion Date
March 31, 2028
Study Completion Date
March 31, 2029
Methotrexate
Starting dose of Methotrexate of 15 mg once a week plus folic acid 1mg daily.
Abatacept
Starting dose may be adjusted as needed at investigator's discretion.
Adalimumab
Starting dose may be adjusted as needed at investigator's discretion.
Azathioprine
Starting dose may be adjusted as needed at investigator's discretion.
Baricitinib
Starting dose may be adjusted as needed at investigator's discretion.
Certolizumab
Starting dose may be adjusted as needed at investigator's discretion.
Etanercept
Starting dose may be adjusted as needed at investigator's discretion.
Golimumab
Starting dose may be adjusted as needed at investigator's discretion.
Hydroxychloroquine
Starting dose may be adjusted as needed at investigator's discretion.
Infliximab
Starting dose may be adjusted as needed at investigator's discretion.
Leflunomide
Starting dose may be adjusted as needed at investigator's discretion.
Minocycline
Starting dose may be adjusted as needed at investigator's discretion.
Rituximab
Starting dose may be adjusted as needed at investigator's discretion.
Sarilumab
Starting dose may be adjusted as needed at investigator's discretion.
Sulfasalazine
Starting dose may be adjusted as needed at investigator's discretion.
Tofacitinib
Starting dose may be adjusted as needed at investigator's discretion.
RECRUITING
University of Nebraska Medical Center, Omaha
University of Nebraska
OTHER